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Dengue virus RNA is trimmed by the 50/30 exoribonuclease XRN1 to produce an abundant, non-coding sub-
genomic flavivirus RNA (sfRNA) in infected cells. In a recent paper in Science, Manokaran et al. (2015) report
that sfRNA binds TRIM25 to evade innate immune sensing of viral RNA by RIG-I.Mosquito-borne flaviviruses such as
Dengue (DENV), West Nile (WNV), and
Yellow fever have a major impact on hu-
man health and are a serious threat in
developing countries. A complex network
of interactions between hosts, mosquito
vectors, and environmental and viral fac-
tors determines the transmission of these
viruses in the field (Guzman and Harris,
2015). As a result, flavivirus epidemics
can be highly dynamic, with different viral
strains co-circulating and/or competing in
the same area. However, the underlying
interactions and factors driving the
replacement of one flaviviral strain by
another have not been clearly defined.
The importance of mosquitoes in flavivi-
rus strain replacement was exemplified
in the well-documented WNV epidemic
in the US in the period 1999–2003. The
now-dominant WN02 virus, carrying an
amino acid change in the structural enve-
lope glycoprotein E, was transmitted
more efficiently by Culex pipiens mosqui-
toes, and this likely contributed to
replacement of the original NY99 strain
(Kilpatrick et al., 2008). Elucidating the
reasons for strain replacement may help
us to understand flavivirus epidemiology
and eventually mitigate virus spread.
In recent work, Manokaran et al. (2015)
set out to find an explanation for the
replacement of epidemic DENV2 from
Puerto Rico (PR-1 clade) by emerging
isolates (PR-2B clade) in the period
1995–2007. Phylogenetic studies of com-
plete genome sequences demonstrated
no significant difference between the
structural proteins of PR-1 and PR-2B.
Instead, the authors discovered that PR-
2B viruses had significant nucleotide
changes in their 30 UTRs. PR-2B concom-
itantly expressed increased levels of
non-coding, subgenomic flavivirus RNA
(sfRNA) relative to viral genomic RNA
(vgRNA). Correspondingly, the emergingNicaraguan DENV2 NI-2B strain, which
replaced the endemic NI-1 strain in
2005, also produced higher sfRNA:
vgRNA ratios, providing a novel link be-
tween sfRNA production and viral epide-
miological fitness.
SfRNA is a 0.5-kb degradation prod-
uct of viral mRNA turnover and is essential
for flavivirus pathogenesis in vertebrates
(Pijlman et al., 2008). Full-length sfRNA
is formed when the 50/30 exoribonucle-
ase XRN1 digests vgRNA but stalls at
the conserved stem loop-II (SL-II) RNA
structure in the 30 UTR with a compact
3D fold and an important pseudoknot
(PK) interaction (Figure 1; Chapman
et al., 2014). XRN1 stalling at the down-
stream SL-IV and dumbbell-1 (DB1) RNA
structures produces the smaller sfRNA2
and sfRNA3, respectively, although bio-
logical functions have primarily been
linked to full-length sfRNA.
The vertebrate innate immune response
against flaviviruses is triggered primarily
by the sensing of viral RNA by retinoic
acid-inducible gene-I-like receptors in
the cytoplasm (RIG-I, MDA5). Binding of
viral RNA to these RIG-I-like receptors
(RLRs) triggers the downstream transcrip-
tion of interferon response factor (IRF)-3/7
and eventually leads to induction of type I
interferon (IFN). How flaviviruses cope
with RLR signaling and subsequent
immune activation remains unclear,
although there is compelling evidence
that sfRNA can effectively antagonize
innate immune pathways (Figure 1).
In weanling mice, WNV sfRNA was
shown to interfere with IFN-a receptor
(IFNAR)-dependent and IRF-3/7-medi-
ated IFN induction (Schuessler et al.,
2012). An interaction between DENV2
sfRNA and the stress granule compo-
nents G3BP1/2 and Caprin was shown
to decrease IFN-stimulated gene (ISG)
expression; however, a direct mechanismCell Host & Microbe 18between IFN signaling and sfRNA is not
known (Bidet et al., 2014). The present
study by Manokaran et al. (2015) sheds
light on the interference of sfRNA with
IFN induction and provides evidence
for binding of DENV2 sfRNA to the ubiqui-
tin ligase tripartite motif protein 25
(TRIM25). TRIM25 normally polyubiquity-
nates RIG-I, a prerequisite for efficient
signaling in response to non-self (viral)
RNA recognition/sensing by RIG-I (Mano-
karan et al., 2015). RNA-immunoprecipi-
tation showed that sfRNA of the emergent
PR-2B virus binds more strongly to
TRIM25, thereby preventing the ubiquiti-
nation-dependent activation of RIG-I
(Figure 1). A similar strategy is used by
influenza A virus, which targets the viral
NS1 protein to TRIM25 to prevent RIG-I
activation and subsequent IFN induction
(Gack et al., 2009). Together, these find-
ings form an intriguing example of conver-
gent evolution of protein- and RNA-based
viral products in different virus families to
inactivate TRIM25.
The finding by Manokaran et al. (2015)
raises the question of which RNA struc-
tures and/or sequence motifs in the
DENV2 30 UTR are responsible for the dif-
ference in IFN induction between PR-1
and PR-2B viruses. Although sfRNA sec-
ondary structures are highly conserved
(Pijlman et al., 2008), its primary sequence
is more variable. Interestingly, in-depth
comparison of the 30 UTR sequences re-
vealed that just three conserved muta-
tions (Figure 1, red dots) between the
DENV PR-1 and PR-2B clade were
responsible for increased sfRNA abun-
dance and TRIM25 binding. Two muta-
tions (A10301G, U10389C) did not disturb
predicted pseudoknot nor stem-loop for-
mation (Chapman et al., 2014; Pijlman
et al., 2008); however, a third muta-
tion (G10331A) would theoretically result
in formation of a weaker pseudoknot, August 12, 2015 ª2015 Elsevier Inc. 133
Figure 1. Inhibition of Innate Immune Pathways by Subgenomic Flavivirus RNA
Subgenomic flavivirus RNA (sfRNA) is formed after de novo (+) vgRNA synthesis by stalling of the host
50/30 exoribonuclease XRN1. sfRNA inhibits multiple innate immune pathways including the IFNAR-
dependent IFN response, stress granule-initiated ISG expression, and RNAi pathways. Manokaran
et al. (2015) now show in Science that sfRNA from DENV2 binds to the ubiquitin ligase TRIM25 and
thereby inhibits vRNA recognition by the cytoplasmic non-self RNA sensor RIG-I. The sfRNA-TRIM25
binding is stronger for DENV2 isolates from the PR-2B clade and might explain the replacement of
the endemic PR-1 clade by PR-2B.
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resistance (Chapman et al., 2014).
Indeed, in an earlier study with DENV2
strain 43, the very same 10331A/10389C
mutations were shown to dramatically
reduce full-length sfRNA expression with
a concomitant increase in the 50 truncated
sfRNA species sfRNA2 and sfRNA3 (Liu
et al., 2010). Curiously, the PR-2B strains
in the present study by Manokaran et al.
(2015) produce more full-length sfRNA,
suggesting that XRN1 stalling is more
complex than predictions from in silico
RNA structure modeling would suggest.
Further studies, e.g., northern blot anal-
ysis (Pijlman et al., 2008; Liu et al., 2010)
or in vitro XRN1 stalling assays (Chapman
et al., 2014) of the sfRNA species ex-
pressed by PR-1 and PR-2B strains,
may help to clarify the molecular basis
for enhanced full-length sfRNA expres-
sion by PR-2B.
Another question that arises from the
discovery by Manokaran et al. (2015) is
whether the sfRNA-TRIM25 interplay can134 Cell Host & Microbe 18, August 12, 2015fully explain the epidemiological strain re-
placements of DENV. Perhaps other
factors in the natural transmission cycle
are involved as well. SfRNA generation
has been demonstrated for mosquito-
borne, tick-borne, no-known-vector, and
insect-specific flaviviruses (ISF). The
conserved generation of sfRNA in ISF
underscores the importance of sfRNA
in insects. Indeed, WNV sfRNA was
demonstrated to inhibit both miRNA
and siRNA-mediated RNA interference,
the primary invertebrate innate immune
response, potentially by acting as a
decoy-substrate for Dicer cleavage
(Figure 1). Interestingly, insect host
specialization leads to highmutation rates
in the 30 UTR of flaviviruses. For DENV2 it
has been reported that the 30 UTR un-
dergoes extensive modification during
replication in mosquito cells, especially
in the SL-II/SL-IV region important for
sfRNA formation (Villordo et al., 2015). It
is possible that sequence differences
between the 30 UTRs of PR-1 and PR-2Bª2015 Elsevier Inc.viruses arose during DENV replication
in mosquitoes and were maintained in
the virus population due to superior innate
immune suppression in the human
host. Competition assays between PR-1
and PR-2B isolates in both vertebrate
and mosquito models could simulate
the DENV2 strain replacement that
occurred between 1995 and 2007 and
may provide further understanding of
this phenomenon.
To conclude, the link between sfRNA
and flaviviral fitness described by Mano-
karan et al. (2015) further emphasizes
the pivotal role of non-coding sfRNA as
regulator of antiviral innate immune path-
ways during flavivirus replication.
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